Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
The sector is experiencing a transitional quarter, hindered by declining gRevlimid sales and the weight of GST impact on overall growth.

The sector is experiencing a transitional quarter, hindered by declining gRevlimid sales and the weight of GST impact on overall growth.

by Team Small News | Oct 22, 2025 | Lupin, Pharma, Torrent Pharma

The pharmaceutical sector is expected to experience a soft quarter in Q2FY26, according to brokerages. This period is seen as a transition phase for the industry, with both positive and negative factors at play. On the positive side, several companies have shown...

Lupin announces plans to construct a new manufacturing facility in Coral Springs, Florida, as reported by Drug Store News.

by Team Small News | Oct 21, 2025 | Lupin, Pharma

Lupin, a pharmaceutical company, has announced plans to build a manufacturing facility in Coral Springs, Florida. The new facility will enable the company to expand its production capabilities and meet the growing demand for its products in the US market. The...

Lupin and Dassault Falcon Jet to bring 600 new employment opportunities to Florida.

by Team Small News | Oct 17, 2025 | Lupin, Pharma

Pharma firm Lupin and Dassault Falcon Jet are set to create 600 new jobs in Florida. Lupin, a global pharmaceutical company, is expanding its presence in the state with a new manufacturing facility. The company will invest $150 million in the project, which is...

Lupin receives one observation from the USFDA for its Somerset facility

by Team Small News | Oct 12, 2025 | Lupin, Pharma

Lupin, a pharmaceutical company, has received one observation from the US Food and Drug Administration (USFDA) for its facility located in Somerset, New Jersey. The USFDA observation is a result of an inspection conducted by the regulatory agency, which identified a...

Lupin Pharmaceuticals is investing $250 million to construct a new manufacturing plant in Coral Springs, expected to create around 200 job opportunities.

by Team Small News | Oct 9, 2025 | Lupin, Pharma

Lupin Pharmaceuticals, a global pharmaceutical company, has announced plans to build a $250 million manufacturing plant in Coral Springs, Florida. The new facility is expected to create approximately 200 jobs in the area, providing a significant boost to the local...

Lupin’s Pithampur Unit 2 facility receives USFDA’s Official Action Indicated (OAI) status.

by Team Small News | Oct 5, 2025 | Lupin, Pharma

Lupin, a pharmaceutical company, has recently received the USFDA OAI (Official Action Indicated) status for its Pithampur Unit 2 facility. The USFDA (United States Food and Drug Administration) is responsible for ensuring the safety and efficacy of drugs and medical...
« Older Entries
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress